Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2005 | 12-2004 | 12-2003 | |
| Sales | N/A | 13 | 77 |
| Operating Expenses | 1,035 | 616 | 482 |
| Operating Income | -1,035 | -603 | -406 |
| Other Income | 1,035 | 603 | 406 |
| Net Income Continuous | -1,010 | -603 | -406 |
| Net Income | $-1,010 | $-603 | $-406 |
| EPS Basic Total Ops | -0.31 | -0.22 | -0.22 |
| EPS Basic Continuous Ops | -0.31 | -0.22 | -0.22 |
| EPS Diluted Total Ops | -0.31 | -0.22 | -0.22 |
| EPS Diluted Continuous Ops | -0.31 | -0.22 | -0.22 |
| EBITDA(a) | $-996 | $-587 | $-387 |